Spatiotemporally Guided Single‐Atom Bionanozyme for Targeted Antibiofilm Treatment
2024

Targeted Antibiofilm Treatment Using a New Bionanozyme

publication 10 minutes Evidence: high

Author Information

Author(s): L. Huang, H. Pu, D.-W. Sun

Primary Institution: South China University of Technology

Hypothesis

Can a spatiotemporally guided single-atom bionanozyme effectively target and treat biofilm infections?

Conclusion

The BioSAzyme effectively inhibits E. coli and MRSA biofilms in vitro and in vivo, demonstrating strong antibiofilm activity.

Supporting Evidence

  • BioSAzyme showed a significant reduction in biofilm biomass compared to control groups.
  • Bacterial survival rates in biofilms treated with BioSAzyme were only 0.36% for E. coli and 1.47% for MRSA.
  • BioSAzyme treatment led to a 95% wound recovery rate in MRSA-infected mice.

Takeaway

Scientists created a special tiny machine that can find and destroy harmful bacteria in sticky layers called biofilms, helping to treat infections better.

Methodology

The study synthesized a copper single-atom nanozyme and tested its antibiofilm efficacy against E. coli and MRSA in vitro and in vivo.

Limitations

The study primarily focused on in vitro and in vivo models, which may not fully represent human conditions.

Statistical Information

P-Value

0.07

Statistical Significance

p<0.001

Digital Object Identifier (DOI)

10.1002/smll.202407747

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication